InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Revenue

InMed Pharmaceuticals had revenue of $1.17M in the quarter ending March 31, 2024, with 13.41% growth. This brings the company's revenue in the last twelve months to $5.63M, up 140.49% year-over-year. In the fiscal year ending June 30, 2023, InMed Pharmaceuticals had annual revenue of $4.14M with 279.61% growth.

• Revenue (ttm): $5.63M
• Revenue Growth: +140.49%
• P/S Ratio: 0.30
• Revenue / Employee: $432,748
• Employees: 13
• Market Cap: 2.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	4.14M	3.05M	279.61%
Jun 30, 2022	1.09M	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-
Jun 30, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.